• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 4. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazinanes Piperazines

Introduction to (S)-6-Methyl-4,7-diazaspiro[2.5]octane 2HCl (CAS No. 1199792-88-5)

(S)-6-Methyl-4,7-diazaspiro[2.5]octane 2HCl is a significant compound in the field of pharmaceutical chemistry, renowned for its unique structural and functional properties. This compound, identified by the CAS number 1199792-88-5, has garnered considerable attention due to its potential applications in drug development and molecular research. The spirocyclic structure of this molecule, characterized by a nitrogen-rich core, makes it a promising candidate for various biochemical interactions.

The synthesis and characterization of (S)-6-Methyl-4,7-diazaspiro[2.5]octane 2HCl involve meticulous attention to stereochemistry, ensuring that the enantiomeric purity is maintained. This is crucial because the stereochemical configuration can significantly influence the biological activity of the compound. Recent advancements in chiral resolution techniques have enabled researchers to achieve high levels of enantiomeric purity, which is essential for its intended applications.

In the realm of pharmaceutical research, (S)-6-Methyl-4,7-diazaspiro[2.5]octane 2HCl has been explored for its potential role in modulating various biological pathways. The nitrogen atoms in its structure provide multiple sites for interaction with biological targets, making it a versatile scaffold for drug design. Studies have indicated that this compound exhibits promising activity in preclinical models, particularly in the context of central nervous system (CNS) disorders.

One of the most intriguing aspects of (S)-6-Methyl-4,7-diazaspiro[2.5]octane 2HCl is its ability to interact with neurotransmitter receptors and enzymes. The spirocyclic framework enhances its binding affinity and selectivity, which are critical factors in drug development. Recent research has highlighted its potential as a precursor for developing novel therapeutic agents targeting neurodegenerative diseases such as Alzheimer's and Parkinson's.

The chemical stability of (S)-6-Methyl-4,7-diazaspiro[2.5]octane 2HCl under various conditions has also been thoroughly investigated. This compound demonstrates remarkable stability in aqueous solutions and at physiological temperatures, making it suitable for formulation into pharmaceutical products. Additionally, its solubility profile allows for easy integration into various drug delivery systems, enhancing its therapeutic potential.

The industrial production of (S)-6-Methyl-4,7-diazaspiro[2.5]octane 2HCl has been optimized to ensure scalability and cost-effectiveness. Advanced synthetic methodologies have been employed to streamline the manufacturing process while maintaining high yields and purity standards. These advancements have made it more feasible to incorporate this compound into large-scale pharmaceutical production.

In conclusion, (S)-6-Methyl-4,7-diazaspiro[2.5]octane 2HCl (CAS No. 1199792-88-5) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and promising biological activities make it a valuable compound for further research and development. As our understanding of molecular interactions continues to evolve, the potential applications of this compound are likely to expand, offering new avenues for therapeutic intervention.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)